A table of contents on imaging, AI, and the infrastructure of care

A multimodal sleep foundation model for disease prediction

Published in Nature Medicine (2025). Stanford-led collaboration on SleepFM, a foundation model for overnight physiology.

Sleep is the longest continuous physiologic recording most humans ever produce. SleepFM asks what happens when a foundation model is trained directly on that signal — across brain, heart, and breath — and then used as a general substrate for predicting disease.

What the paper shows

The authors train a multimodal foundation model on large-scale polysomnography — EEG, ECG, respiratory effort, oximetry, EMG, and related channels — from hundreds of thousands of overnight studies. Rather than optimising a single classifier for a single condition, they learn a shared representation of overnight physiology that can be adapted, with minimal supervision, to downstream tasks.

Across those tasks, SleepFM predicts disease onset and progression spanning cardiometabolic (hypertension, atrial fibrillation, type-2 diabetes), neurologic (Parkinson's, cognitive decline), and psychiatric (depression) domains — often outperforming models trained only on the target label, and doing so from a single night of passively collected signal.

Why it matters for the thesis

SleepFM is the sleep analogue of what CT-derived VO₂max estimation aims to do for imaging: extract a high-value physiologic readout from data that is already being captured, without adding a new test to the clinical pathway. The transferable idea is that foundation models make the marginal cost of a new prediction close to zero once the substrate exists.

The measurement bottleneck in medicine is rarely the sensor. It is the workflow that surrounds the sensor.

Overnight PSGs, contrast-enhanced CTs, ambulatory ECGs, and echoes all contain far more physiologic information than the report ever extracts. A foundation model turns those recordings into a general-purpose feature space that specialists can query for questions the original study was never ordered to answer.

Open questions

Generalisation across sleep-lab hardware, demographic shift, and home-based recordings from consumer devices remains the honest limit of any PSG-trained model. The same is true of imaging foundation models trained on tertiary-centre scanners. Prospective validation across sites, and pre-specified analysis of subgroup performance, will decide whether SleepFM becomes clinical infrastructure or a benchmark trophy.

The most important number your doctor has never measured

By Joel Selanikio, MD. Originally published at Future Health.

There's a number that predicts whether you'll be alive in ten years better than your blood pressure, your cholesterol, your BMI, or whether you smoke. It's called VO2 max. And you've probably never heard your doctor mention it.

The number

VO2 max measures the maximum amount of oxygen your body can use during intense exercise. It is a single figure — milliliters of oxygen per kilogram of body weight per minute — that captures how well your heart, lungs, blood vessels, and muscles work together. Researchers call the broader concept cardiorespiratory fitness, or CRF. VO2 max is how you measure it.

And it may be the single most powerful predictor of whether you live or die that medicine has ever identified.

In 2022, a study of more than 750,000 U.S. veterans found that even modest improvements in VO2 max were associated with a 13 to 15 percent reduction in mortality risk — regardless of age, BMI, sex, or existing conditions. A 46-year follow-up of over 5,000 men in Copenhagen found that each 1 ml/kg/min increase was associated with 45 additional days of life.

A 2018 Cleveland Clinic analysis of 122,007 adults found that those with the lowest VO2 max had four times the mortality risk of those with the highest. The mortality difference between the least fit and the most fit people was larger than the difference between non-smokers and smokers, or between people with and without diabetes.

The recommendation no one followed

In 2016, the American Heart Association published a landmark scientific statement arguing that cardiorespiratory fitness should be treated as a clinical vital sign — measured routinely, alongside blood pressure, heart rate, and temperature. At a minimum, all adults should have it estimated every year.

That was nearly a decade ago. Has your doctor measured it? Mentioned it?

The single most powerful predictor of mortality we have doesn't fit inside a 15-minute office visit. So it doesn't get done.

The migration

While the clinical system was busy not measuring VO2 max, someone else was — on millions of people's wrists. Apple Watch has been estimating VO2 max since 2020, passively, using heart-rate sensors and GPS during outdoor walks, runs, and hikes. No mask. No technician. No appointment.

A wrist estimate is not as good as a lab test. But it is better than a gold-standard test that never gets done. And because wearables measure it every time you take a brisk walk, they capture trajectory — response to training, illness, and seasonal variation.

Why personalized customer experiences are the future of healthcare

By Eangelica Aton. Originally published in The AI Journal.

The typical healthcare customer service experience probably sounds familiar: a customer calls their insurer, navigates a labyrinth of menus, and is promptly placed on hold. It is a toss-up whether they actually get the help they need.

The pandemic reset expectations

The pandemic turned shaky customer service from an inconvenience into a deal breaker. In 2021, 58% of healthcare customers said they had higher service expectations than the year before.

Conversation intelligence AI can present relevant plan information to representatives in real time, reduce call times, and free them to focus on being engaged and empathetic listeners. Omnichannel operations meet patients on the channel they already prefer — phone, portal, or telehealth.

AI should remove the work around the relationship, not replace the relationship itself.

The best healthcare AI will not feel like a product

By Roberto Cruz, Co-Founder & CEO, TietAI.

Every healthcare AI demonstration follows the same script. The interface is polished. The patient is summarised in seconds. Then it reaches a hospital on a Monday morning, and nobody opens it.

The question is how the value of the AI becomes part of the work clinicians are already doing.

Embedded, not absent

The most valuable systems will increasingly operate behind the scenes — preparing information before it is requested, reconciling records before discrepancies reach the clinician, and routing work to the correct team. They act through the systems hospitals already run.

Capacity is the real economic case

Healthcare is under capacity pressure, not just financial pressure. The companies that win will help existing institutions do materially more with the people and systems they already have. That demands proof in operational terms: time returned, delays removed, errors prevented, capacity created.

The best healthcare AI will not be the system clinicians remember using. It will be the reason the work was easier to do.

Automated detection of traumatic white matter injury using voxel-based morphometry of DTI

Le TH, Mukherjee P, Manley GT, et al. Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, 2005.

Traumatic brain injury often leaves white matter damage that conventional scans miss. This early work asked whether diffusion tensor imaging, paired with voxel-based morphometry, could make that injury visible and quantifiable.

The clinical problem

Closed head trauma produces edema, hemorrhage, and contusions, but diffuse axonal injury — shearing of axons from rotational acceleration — is a major source of long-term disability. Conventional CT and MR often underestimate its extent. T2* gradient echo improves on CT by detecting blood products, yet most DAI lesions are non-hemorrhagic. FLAIR detects some of these foci, but still misses a large fraction of the true white matter burden.

The result is a gap between what imaging reports and what patients experience. A scan can read as nearly normal while cognitive, psychiatric, and functional deficits persist.

Why DTI changes the picture

Diffusion tensor imaging measures the directional motion of water in brain tissue. In healthy white matter, water diffusion is anisotropic — it moves preferentially along axonal bundles. Fractional anisotropy captures that directionality. When axons are sheared or demyelinated, FA drops.

Unlike conventional sequences that look for focal lesions, DTI probes microstructural integrity across the entire white matter skeleton. That makes it inherently suited to diffuse injury patterns that evade lesion-counting approaches.

Voxel-based morphometry against a normal database

The authors built a normal FA database from 15 adult volunteers, spatially normalizing each subject's DTI data to a standardized FA template. Individual trauma patients — 11 in this pilot — were then registered to the same template and compared voxel-by-voxel against the normal distribution.

This is the imaging analogue of a reference-range laboratory test: instead of relying on radiologist impression, the analysis flags voxels where a patient's FA deviates from expected normal variation. The automation removes inter-reader variability and scales to whole-brain screening.

Parallel imaging at 3T

High-field DTI near the skull base is traditionally degraded by susceptibility artifacts. By using parallel imaging, the team reduced geometric distortion enough to assess inferior frontal and temporal regions — areas particularly vulnerable to trauma and previously difficult to evaluate with DTI.

Technical advances in acquisition are what turn a promising biomarker into a clinically usable one.

Relevance today

This 2005 study prefigures the current wave of quantitative neuroimaging: normative atlases, voxel-wise deviation mapping, and AI-assisted detection of subtle injury. The same logic — compare a patient's imaging against a learned distribution of normal — now powers large-scale efforts in brain age estimation, lesion detection, and radiomic phenotyping.

For the thesis, the paper is a reminder that the hardest clinical problems are often measurement problems first. Whether the target is white matter integrity or cardiorespiratory fitness, the path is similar: acquire a quantitative signal, establish a normative reference, and automate the comparison so clinicians can act on it.